DNA recognition by two mitoxantrone analogues: Influence of the hydroxyl groups
- 5 February 1996
- journal article
- Published by Wiley in FEBS Letters
- Vol. 379 (3) , 269-272
- https://doi.org/10.1016/0014-5793(95)01528-0
Abstract
The clinically useful anticancer drug mitoxantrone intercalates preferentially into 5′-(A/T)CG and 5′-(A/T)CA sites on DNA. The 5,8 hydroxyl substituents on its anthracenedione chromophore are available to interact with the double helix. Footprinting experiments with two anthraquinone derivatives structurally related to mitoxantrone and ametantrone have been undertaken to assess the influence of the hydroxyl groups on the DNA recognition process. The results confirm that they do play a role in the recognition of preferred nucleotide sequences and suggest that the binding of anthraquinones to a 5′-(A/T)CG site is dependent on the presence of the 5,8 hydroxyl substituents whereas binding to 5′-(A/T)CA sites appears to proceed just as well without them.Keywords
This publication has 21 references indexed in Scilit:
- Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase IIBiochemistry, 1993
- NAD(P)H (quinone acceptor) oxidoreductase (DT-diaphorase)-mediated two-electron reduction of anthraquinone-based antitumour agents and generation of hydroxyl radicalsBiochemical Pharmacology, 1992
- MitoxantroneDrugs, 1991
- MitoxantroneAnti-Cancer Drugs, 1990
- Involvement of Hydroxyl Radical Formation and Dna Strand Breakage in the Cytotoxicity of Anthraquinone Antitumour AgentsFree Radical Research Communications, 1990
- Stopped-flow kinetic analysis of the interaction of anthraquinone anticancer drugs with calf thymus DNA, poly[d(G-C)].cntdot.poly[d(G-C)], and poly[d(A-T)].cntdot.poly[d(A-T)]Biochemistry, 1986
- DNA sequence preferences for the anti‐cancer drug mitoxanthrone and related anthraquinones revealed by DNase I footprintingFEBS Letters, 1986
- Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acidsBiochemistry, 1985
- Dissociation kinetics of DNA-anthracycline and DNA-anthraquinone complexes determined by stopped-flow spectrophotometryBiochemical Pharmacology, 1985
- Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acidsBiochemical Pharmacology, 1981